Skip to main content

Scottish Molecular Dx Firm DestiNA Genomics Bags $1.5M in Investments

NEW YORK (GenomeWeb) – The Scottish molecular diagnostics firm DestiNA Genomics has received €1.2 million ($1.5 million) in equity investments that it will use to commercialize novel tests for cancer and infectious diseases, the economic development agency Scottish Enterprise said this week.

The new funding for the Edinburgh-based company was led by Vitro Group of Spain, the Scottish Investment Bank (part of Scottish Enterprise), Old College Capital, and private investors in the UK, Spain, Belgium, and Saudi Arabia.

A spinout from the University of Edinburgh, DestiNA formed in 2010 based on inventions and patents developed by Juan Diaz Mochon and Mark Bradley of the university's School of Chemistry.

The firm's technology combines aldehyde modified Smart Nucleobases with peptide nucleic acid capture probes, or DGL probes, for use in chemical nucleic acid and mutation testing, according to DestiNA's website. The company states that its technology can detect DNA or RNA, does not produce false positives, and that its reagents may be developed to achieve the speed and accuracy required in situations such as accidents and emergencies.

DestiNA plans to collaborate closely with Master Diagnostica, a subsidiary of Vitro Group, to develop a colon cancer assay, and it has been developing direct collaborations with other research and commercial groups in the UK and Italy.

The Smart Nucleobase patent has been approved for grant in the US and in Europe, Scottish Enterprise said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.